164 results on '"Coghlan, John G."'
Search Results
2. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis
3. Deep phenotyping of p.(V142I)‐associated variant ATTR amyloid cardiomyopathy: distinct from wild‐type ATTR amyloidosis?
4. Recurrent episodes of Takotsubo cardiomyopathy in systemic sclerosis
5. Balloon pulmonary angioplasty outcomes in patients previously treated by pulmonary endarterectomy surgery are inferior to those of inoperable patients
6. Recurrent episodes of Takotsubo cardiomyopathy in systemic sclerosis
7. Major lung complications of systemic sclerosis
8. Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis
9. Right ventricular-pulmonary artery coupling in chronic thromboembolic pulmonary hypertension
10. Right ventricular–pulmonary artery coupling in chronic thromboembolic pulmonary hypertension
11. Acute lung injury after balloon pulmonary angioplasty results in a similar haemodynamic response and possible clinical advantage at follow-up
12. Acute lung injury after balloon pulmonary angioplasty results in a similar haemodynamic response and possible clinical advantage at follow‐up
13. Dynamic prediction of pulmonary hypertension in systemic sclerosis using landmark analysis
14. Mendelian randomisation and experimental medicine approaches to IL-6 as a drug target in PAH
15. Dynamic Prediction of Pulmonary Hypertension in Systemic Sclerosis Using Landmark Analysis.
16. Superior outcome with direct catheter laboratory access vs ED-activated primary percutaneous coronary intervention
17. Author Correction: Major lung complications of systemic sclerosis
18. Characteristics and Survival of Anti–U1 RNP Antibody–Positive Patients With Connective Tissue Disease–Associated Pulmonary Arterial Hypertension
19. Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension
20. An Update on the Evaluation and Management of Pulmonary Hypertension in Scleroderma
21. Balloon Pulmonary Angioplasty: State of the Art
22. Borderline Mean Pulmonary Artery Pressure in Patients With Systemic Sclerosis: Transpulmonary Gradient Predicts Risk of Developing Pulmonary Hypertension
23. Improving the Detection of Pulmonary Hypertension in Systemic Sclerosis Using Pulmonary Function Tests
24. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis
25. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience
26. Clinical experience with bosentan and sitaxentan in connective tissue disease-associated pulmonary arterial hypertension
27. Grossly Abnormal Ventilation/Perfusion SPECT Study in Idiopathic Pulmonary Arterial Hypertension Without Thromboembolism
28. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension
29. The natriuretic peptides and their role in disorders of right heart dysfunction and pulmonary hypertension
30. Genetic determinants of risk in pulmonary arterial hypertension:international genome-wide association studies and meta-analysis
31. Systemic sclerosis involving the heart
32. Soluble thrombomodulin concentration is raised in scleroderma associated pulmonary hypertension
33. Genetic determinants of risk and survival in pulmonary arterial hypertension
34. Oral abstracts 3: RA Treatment and outcomesO13. Validation of jadas in all subtypes of juvenile idiopathic arthritis in a clinical setting
35. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis.
36. Pulmonary Arterial Hypertension With Abnormal V/Q Single-Photon Emission Computed Tomography
37. Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial
38. Erratum to: An Update on the Evaluation and Management of Pulmonary Hypertension in Scleroderma
39. 119 V/q single-photon emission computed tomography in non-thromboembolic pulmonary arterial hypertension
40. Two‐dimensional knowledge‐based volumetric reconstruction of the right ventricle documents short‐term improvement in pulmonary hypertension
41. Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic Sclerosis
42. Reply
43. Native T1 myocardial tissue characterisation in patients with pulmonary hypertension: findings from International T1 Multicentre Study
44. Evidence for the Involvement of Type I Interferon in Pulmonary Arterial Hypertension
45. Abnormal systolic and diastolic LV motion by novel tissue phase mapping accounts for functional capacity in pulmonary hypertension
46. Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient
47. TCT-684 OCT As A Rule Out Test For Thromboembolism In Pulmonary Arterial Hypertension: Insights From A OCT Study Of The Pulmonary Vascular Tree.
48. Bochdalek Hernia Causing Pulmonary Hypertension
49. Safety and Efficacy of Ambrisentan in the Treatment of Pulmonary Arterial Hypertension
50. Prognostic value of negative dobutamine stress echo in women with intermediate probability of coronary artery disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.